Nateglinide was very well tolerated. The overall incidence of AEs, other than symptoms of hypoglycemia, was low and similar among all treatment groups. No deaths occurred during the study ...

Objective: The purpose of this study was to evaluate the metabolic effectiveness, safety, and tolerability of nateglinide in subjects with impaired glucose tolerance (IGT) and to identify a dose ...